Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q1 2021
- Shares held
- 12.5M
- −650.2K (−5.0%) vs. Q1 2021
- Total value
- $28.1M
- −$7.51M (−21.1%) vs. Q1 2021
- New holders
- 2
- 5 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 5,940,796 | $13.4M | 0.17% | 00.0% | Unchanged |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $10.9M | 0.08% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 1,263,408 | $2.84M | 0.32% | 00.0% | Unchanged |
| Vanguard Group Inc | 133,215 | $300.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 92,600 | $208.0K | 0.00% | −29,249−24.0% | Reduced |
| Geode Capital Management, LLC | 49,077 | $110.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 44,180 | $99.0K | 0.00% | +11,786+36.4% | Added |
| WealthTrust Axiom LLC | 39,500 | $88.0K | 0.03% | +1,000+2.6% | Added |
| Bridgeway Capital Management, LLC | 34,600 | $78.0K | 0.00% | −75,000−68.4% | Reduced |
| Alberta Investment Management Corp | 25,000 | $56.0K | 0.00% | +25,000 | New |
| Northern Trust Corp | 11,414 | $26.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 10,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,187 | $10.0K | 0.00% | +2,950+238.5% | Added |
| First Manhattan Co | 3,500 | $7.00K | 0.00% | +1,600+84.2% | Added |
| UBS Group AG | 2,137 | $5.00K | 0.00% | −241−10.1% | Reduced |
| Wells Fargo & Company | 33 | $0 | 0.00% | +9+37.5% | Added |
| Barclays PLC | 100 | $0 | 0.00% | +100 | New |
| FMR LLC | 0 | $0 | 0.00% | −576,500−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,617−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −16−100.0% | Sold out |